Oncolytics Biotech Inc.ONCYNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank93
3Y CAGR+86.1%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+86.1%/yr
vs -30.6%/yr prior
Acceleration
+116.8pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 16.80 | +291.8% |
| 2023 | 4.29 | -11.3% |
| 2022 | 4.83 | +85.6% |
| 2021 | 2.60 | -47.4% |
| 2020 | 4.95 | +100.4% |
| 2019 | -1267.26 | -19946.4% |
| 2018 | 6.39 | -43.3% |
| 2017 | 11.26 | +255.0% |
| 2016 | 3.17 | +85.8% |
| 2015 | 1.71 | - |